Health Advocate program for young liver transplant recipients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The HEAL-Tx Transition of Care Pilot is an intervention designed to integrate a Health Advocate into the transplant team to assist adolescents transitioning to adult liver transplant care. This pilot program aims to assess the feasibility and acceptability of the Health Advocate's role, which includes coordinating medical care, providing financial assistance, and connecting patients with community resources. By focusing on adolescents aged 18-25 who have received a liver transplant over a year ago, the study seeks to improve self-management and communication between patients and healthcare providers. The effectiveness of this intervention will be measured using the RE-AIM framework.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Patient has received a liver transplant \>1 year ago
2. Study team has screened patient and discussed with the primary transplant practitioner that patient may benefit from the Health Advocate program.
3. Patient has an unmet social risk (e.g., food insecurity) or MLVI \>/= 2.0.
4. Patient will be transferred to adult transplant team in \<6 months.
5. Patient can read and write English or Spanish
6. Patient is between 18-25 years old and can provide informed consent.
7. Patient has a working phone and smart device capable of video and/or audio virtual visits via Zoom.

Exclusion Criteria:

* Patient has significant cognitive impairment.
* Does not meet age criteria
* Patient is a ward of the state.
* Non-English, non-Spanish speakers.
* Non-US residents.

Where it's running

• University of California San Francisco
  San Francisco, California, United States Recruiting
• Children's Healthcare of Atlanta
  Atlanta, Georgia, United States Recruiting

Study contacts

• Principal investigator: Sharad Wadhwani, MD, MPH — University of California, San Francisco
• Study coordinator: Sharad Wadhwani, MD, MPH
• Email: sharad.wadhwani@ucsf.edu
• Phone: 510-428-3058

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Expanding HIV-positive donor livers for HIV-positive recipients

  This study tests whether liver transplants from HIV-positive donors to HIV-positive recipients are safe regarding opportunistic infections and cancer.

  Recruiting at 2 sites National Institute of Allergy and Infectious Diseases (NIAID) · Baltimore, Maryland and 1 other locations · NCT07778459

• Magnetic Resonance Cholangiopancreatography to help living liver donors and their recipients

  This study tests whether preoperative MRCP imaging can help select living liver donors and reduce biliary complications in recipients.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi · NCT07715500

• Reducing Immunosuppression by 50% in Young Liver Transplant Recipients

  This study tests whether cutting the immunosuppressive medicine by half in children with liver transplants is safe and effective.

  Recruiting at 7 sites Phase 2 National Institute of Allergy and Infectious Diseases (NIAID) · San Francisco, California and 10 other locations · NCT07549503

• Preoperative Carbohydrate Loading Before Liver Transplant

  This study tests whether drinking a carbohydrate beverage before anesthesia helps liver transplant patients recover faster.

  Recruiting Medical University of Warsaw · Warsaw · NCT07519057

• Doctor counseling plus smartphone apps to support healthy eating and activity after liver or kidney transplant

  This program tries whether doctor-delivered lifestyle counseling combined with two smartphone apps can help people aged 60 and older who had a liver or kidney transplant eat healthier and be more active.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, BO · NCT07305012

• Long-term health of children born to mothers who had a solid organ transplant

  This project will look for long-term heart, kidney, and immune system problems in people aged 16 and older who were born to mothers who had a kidney, liver, pancreas, heart, or lung transplant.

  Recruiting University Medical Center Groningen · Groningen, Provincie Groningen · NCT07291258

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.